INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Income Statement [Abstract]
PATIENT REVENUES, net	$ 141,285	$ 141,500
EXPENSES:
Operating	112,278	110,667
Lease and rent expense	13,713	13,743
Professional liability	2,775	2,670
General and administrative	8,139	8,973
Depreciation and amortization	2,881	2,487
Total expenses	139,786	138,540
OPERATING INCOME	1,499	2,960
OTHER INCOME (EXPENSE):
Gain on sale of investment in unconsolidated affiliate	0	733
Other income	51	0
Interest expense, net	(1,669)	(1,483)
Total other expense	(1,618)	(750)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(119)	2,210
BENEFIT (PROVISION) FOR INCOME TAXES	38	(862)
INCOME (LOSS) FROM CONTINUING OPERATIONS	(81)	1,348
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax benefit of $11 and $9, respectively	(22)	(15)
NET INCOME (LOSS)	$ (103)	$ 1,333
Per common share – basic
Per common share – basic, Continuing operations (dollars per share)	$ (0.01)	$ 0.22
Per common share – basic, Discontinued operations (dollars per share)	0.00	0.00
Net income (loss) per common share – basic (dollars per share)	(0.01)	0.22
Per common share – diluted
Per common share – diluted, Continuing operations (dollars per share)	(0.01)	0.21
Per common share – diluted, Discontinued operations (dollars per share)	0.00	0.00
Net income (loss) per common share – diluted (dollars per share)	(0.01)	0.21
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK (dollars per share)	$ 0.055	$ 0.055
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (shares)	6,314	6,233
Diluted (shares)	6,314	6,440